Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|January 22, 2005
Upregulation of endogenous angiogenesis inhibitors: a mechanism of action of metronomic chemotherapySylvia S W Ng, William D Figg
Biomedicines|December 23, 2022
Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal AdenocarcinomaSylvia S W Ng, Laura A Dawson
Surgical Oncology Clinics of North America|November 13, 2025
Adjuvant Chemoradiotherapy for Pancreatic AdenocarcinomaSylvia S W Ng, Sheron Perera, Natalie G Coburn
Cancer Research|February 12, 2004
Taxane-mediated antiangiogenesis in vitro: influence of formulation vehicles and binding proteinsSylvia S W Ng, William D Figg, Alex Sparreboom
Molecular Cancer Therapeutics|December 21, 2002
Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinomaSylvia S W Ng, Ming-Sound Tsao, Trudey Nicklee, et al.
Nuclear Medicine and Biology|August 17, 2011
Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumorsRipen Misri, Katayoun Saatchi, Sylvia S W Ng, et al.
NPJ Precision Oncology|July 23, 2020
Association of pro-inflammatory soluble cytokine receptors early during hepatocellular carcinoma stereotactic radiotherapy with liver toxicitySylvia S W Ng, Hong Zhang, Lisa Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient miceSylvia S W Ng, Gordon R MacPherson, Michael Gütschow, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Assessment of vessel size by MRI in an orthotopic model of human pancreatic cancerJennifer A Flexman, Andrew Yung, Donald T T Yapp, et al.
Journal of Medicinal Chemistry|August 22, 2003
Thalidomide metabolites and analogues. 3. Synthesis and antiangiogenic activity of the teratogenic and TNFalpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidineFrederick A Luzzio, Alexander V Mayorov, Sylvia S W Ng, et al.
Pageof 4